Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $21.00

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned a consensus rating of “Hold” from the six brokerages that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $21.00.

Several equities research analysts have commented on MD shares. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, November 10th. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Monday, December 29th.

Insider Buying and Selling at Pediatrix Medical Group

In other Pediatrix Medical Group news, CEO Mark S. Ordan sold 23,000 shares of Pediatrix Medical Group stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $22.41, for a total transaction of $515,430.00. Following the completion of the transaction, the chief executive officer owned 302,805 shares in the company, valued at approximately $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael A. Rucker sold 10,478 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $23.00, for a total transaction of $240,994.00. Following the completion of the sale, the director directly owned 59,101 shares in the company, valued at $1,359,323. This trade represents a 15.06% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. LSV Asset Management lifted its stake in Pediatrix Medical Group by 51.1% in the 4th quarter. LSV Asset Management now owns 462,200 shares of the company’s stock valued at $9,886,000 after buying an additional 156,400 shares in the last quarter. Global Retirement Partners LLC lifted its position in shares of Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after acquiring an additional 1,365 shares in the last quarter. ProShare Advisors LLC boosted its stake in shares of Pediatrix Medical Group by 4.6% during the fourth quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock valued at $360,000 after acquiring an additional 734 shares during the last quarter. TD Private Client Wealth LLC purchased a new stake in Pediatrix Medical Group during the 4th quarter worth about $39,000. Finally, Allworth Financial LP raised its stake in Pediatrix Medical Group by 1,177.5% in the 4th quarter. Allworth Financial LP now owns 10,833 shares of the company’s stock valued at $232,000 after purchasing an additional 9,985 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

NYSE MD opened at $20.92 on Thursday. The stock has a market capitalization of $1.80 billion, a price-to-earnings ratio of 11.01 and a beta of 0.76. The business’s 50 day moving average is $21.87 and its two-hundred day moving average is $19.02. Pediatrix Medical Group has a 12-month low of $11.84 and a 12-month high of $24.99. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.65.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.